Global In-Vitro Toxicology Testing market size is expected to reach $20.87 billion by 2030 at 10.3%, growing healthcare expenditure fuels in-vitro toxicology testing market growth
Read MoreThe In-vitro Colorectal Cancer Screening Tests market will reach $1.82 billion by 2030 at 6.8%, driven by rising early detection awareness
Read MoreGlobal Invisible Orthodontics market size is expected to reach $11.82 billion by 2030 at 13.5%, segmented as by clear aligners, invisalign, smiledirectclub, candid, clearcorrect, other brands
Read MoreGlobal Invasive Fungal Infections market size is expected to reach $10.1 billion by 2030 at 5.2%, segmented as by candidemia and invasive candidiasis, bloodstream infections, disseminated candidiasis
Read MoreThe invasive ductal carcinoma therapeutics market is expected to reach $13.6 billion by 2030, growing at an 8.5% CAGR, driven by targeted therapies, HER2 treatments, and precision oncology.
Read MoreGlobal Invasive Aspergillosis Therapeutics market size is expected to reach $1.42 billion by 2030 at 4.5%, fungal infections propel the growth of the market
Read MoreGlobal Intussusception market size is expected to reach $5.68 billion by 2030 at 4%, segmented as by idiopathic intussusception, childhood idiopathic intussusception, adult idiopathic intussusception
Read MoreGlobal Intravenous Solutions market size is expected to reach $21.73 billion by 2030 at 7.9%, segmented as by total parenteral nutrition (tpn), carbohydrate solutions, amino acid solutions, lipid solutions, electrolyte solutions
Read MoreGlobal Intravenous (IV) Ibuprofen market size is expected to reach $16.41 billion by 2030 at 11.8%, rising prevalence of pain disorders fueling the growth of the market due to increasing demand for effective pain management
Read MoreThe IV hydration therapy market is projected to reach $4.85 billion by 2030, growing at 9.9% CAGR, driven by wellness services, at-home care, and customized nutrient infusion therapies.
Read More